Supportive Care in Cancer最新文献

{"title":"Experiences and coping strategies related to financial toxicity among frail older colorectal cancer survivors in China: a qualitative study.","authors":"Shuping Zhang, Qingfeng Li, Mingchao Du, Shaohua Hu, Li Zhang, Yanyan Zhang, Jie Zhang, Qiuxia Wang, Qianqian Zhang","doi":"10.1007/s00520-025-09396-8","DOIUrl":"https://doi.org/10.1007/s00520-025-09396-8","url":null,"abstract":"<p><strong>Purpose: </strong>Cancer-related financial toxicity (FT) plays a key role in patients' disease prognosis, well-being, and quality of life. This study aimed to explore the experiences and coping strategies related to FT among frail older colorectal cancer (CRC) survivors in China.</p><p><strong>Methods: </strong>This study adopted a descriptive qualitative approach. Individual interviews were performed with 10 frail older CRC patients at a local hospital from March 2024 to August 2024. Relevant data were analyzed using the Colaizzi's phenomenological analysis.</p><p><strong>Results: </strong>The experiences of FT among frail older CRC patients included (1) insufficient economic income and inadequate medical security; (2) long course of cancer treatment and unaffordability of financial burden; (3) the vulnerability of household economies; and (4) under high psychological pressure and a sense of financial uncertainty. Meanwhile, the coping strategies to mitigate the impacts of FT in this population were as follows: (1) utilizing medical security and insurance policies to reduce FT; (2) financial planning, support, and sharing of responsibilities among family members; and (3) self-psychological adjustment and family members' emotional support.</p><p><strong>Conclusion: </strong>Mitigating FT in frail older CRC survivors is crucial for improving their disease outcomes and quality of life. Understanding the experiences related to FT and identifying relevant coping strategies in this population may contribute to formulating medical and health policies for protecting these patients and their families from the adverse effects of FT. Future studies should be placed on developing effective interventions and providing personalized support for this population to alleviate FT.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"361"},"PeriodicalIF":2.8,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dexamethasone dose-dependently attenuates docetaxel-induced peripheral neuropathy in breast cancer treatment.","authors":"Ryota Kanno, Yoshitaka Saito, Yoh Takekuma, Masato Takahashi, Tomohiro Oshino, Mitsuru Sugawara","doi":"10.1007/s00520-025-09427-4","DOIUrl":"https://doi.org/10.1007/s00520-025-09427-4","url":null,"abstract":"<p><strong>Purpose: </strong>Peripheral neuropathy is one of the most problematic adverse effects of docetaxel. We previously reported that dexamethasone (DEX) prevents taxane-associated acute pain syndrome (T-APS) in a dose-dependent manner, which might be a partial manifestation of chemotherapy-induced peripheral neuropathy (CIPN), in breast cancer treatment. Therefore, this study examined the dose-dependent prophylactic efficacy of DEX against CIPN.</p><p><strong>Methods: </strong>Female patients with breast cancer receiving docetaxel-containing treatments (75 mg/m²) were divided into two groups according to DEX dosage on days 2-4; an 8 mg group (n = 56) and a 4 mg group (n = 28) and retrospectively evaluated. The primary endpoint in this study was defined as the development of grade ≥ 2 CIPN during 4 cycles of the treatment.</p><p><strong>Results: </strong>The incidence of grade ≥ 2 CIPN was 32.1% in the 4 mg group and 10.7% in the 8 mg group and was significantly lower in the 8 mg group (P = 0.03). The incidence of all-grade CIPN was lower in the 8 mg group than in the control group, although the difference was not statistically significant (P = 0.06). Onset time of all-grade and grade ≥ 2 CIPN in the 8 mg group was significantly delayed compared to that in the 4 mg group (P = 0.003 and 0.01, respectively). Additionally, 8 mg/day of DEX was identified as a preventive factor for all-grade CIPN, although the evaluation of grade ≥ 2 symptoms was not possible.</p><p><strong>Conclusion: </strong>Our study found that DEX attenuated docetaxel-induced CIPN in a dose-dependent manner during real-world breast cancer treatment. Further studies are needed to develop better CIPN management strategies.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"360"},"PeriodicalIF":2.8,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"When East meets West: incorporating Baduanjin, a traditional Chinese Qigong exercise, in supportive care for cancer patients.","authors":"Isaac K S Ng","doi":"10.1007/s00520-025-09423-8","DOIUrl":"https://doi.org/10.1007/s00520-025-09423-8","url":null,"abstract":"","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"359"},"PeriodicalIF":2.8,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Developing and assessing a vomiting-free ward workflow for gynecological patients receiving chemotherapy.","authors":"Xin Dan, Tang-Lin Chen, Ya-Lin Tian, Yan Huang, Jian-Hua Ren, Ru-Tie Yin, Ya-Lin He","doi":"10.1007/s00520-025-09422-9","DOIUrl":"https://doi.org/10.1007/s00520-025-09422-9","url":null,"abstract":"<p><strong>Background: </strong>Chemotherapy-induced nausea and vomiting (CINV) significantly diminishes the quality of life (QoL) for patients undergoing early and late-stage cancer treatments. Despite preventive antiemetic measures, CINV remains a challenge, with limited response rates. CINV adversely affects not only patients' physical health but also their psychological well-being, social interactions, and treatment adherence.</p><p><strong>Objective: </strong>This study aimed to evaluate the impact of a vomiting-free ward initiative on managing CINV and its effects on the psychological well-being and QoL of gynecological cancer patients receiving chemotherapy.</p><p><strong>Method: </strong>In this study, 960 gynecological oncology patients receiving inpatient chemotherapy at a premier obstetrics and gynecology hospital in Sichuan Province were enrolled from January to December 2023. They were evenly divided into intervention and control groups based on their admission dates. Both groups underwent standard care, and the intervention group followed a vomiting-free ward protocol. The effectiveness of this specialized ward was evaluated using the Multinational Association of Supportive Care in Cancer (MASCC) Antiemesis Tool, the Functional Living Index-Emesis (FLIE), and the Hospital Anxiety and Depression Scale (HADS).</p><p><strong>Results: </strong>The intervention group showed significant improvements in the frequency and severity of both acute and delayed CINV compared to the control group. Furthermore, there was a 9.7% and 7.2% decrease in the impact of severe nausea and vomiting on leisure activities and a 6.9% and 8.6% reduction in how moderate to severe nausea and vomiting affected daily living, respectively. The introduction of the vomiting-free ward significantly reduced levels of patient anxiety (t = - 3.148, P < 0.001) and depression (t = - 3.223, P < 0.001) compared to standard care.</p><p><strong>Conclusion: </strong>The implementation of a vomiting-free ward effectively mitigates nausea and vomiting, enhances QoL, and decreases anxiety and depression among gynecological oncology patients. This innovative approach can be integrated into clinical practice, providing valuable insights and guidelines for healthcare professionals.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 4","pages":"358"},"PeriodicalIF":2.8,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A systematic review and meta-analysis of side effects influenced by non-surgical treatments in African cancer patients.","authors":"Omolola Salako, Muhammad Y Habeebu, Paul T Okediji, Adaorah F Enyi, Kehinde S Okunade, Gabriel T Fagbenro, Blossom A Maduafokwa, Oghenekome O Agha, Kamaldeen Abdulraheem, Matthew J Allsop","doi":"10.1007/s00520-025-09293-0","DOIUrl":"https://doi.org/10.1007/s00520-025-09293-0","url":null,"abstract":"<p><strong>Background: </strong>Cancer treatments such as chemotherapy immunotherapy and radiotherapy are associated with serious adverse effects that affect a patient's physiological functioning and physical appearance, contribute to financial toxicity, reduce quality of life, and increase the risk of treatment discontinuation. This systematic review aims to describe treatment-related side effects associated with non-surgical cancer treatment and clinical factors that influence the severity of side effects experienced among African cancer patients.</p><p><strong>Method: </strong>A systematic search of primary research studies reporting side effects of chemotherapy, radiotherapy, hormone therapy, targeted therapy, and immunotherapy among patients in African countries was undertaken across four databases (Medline (PubMed), ClinicalTrials.gov, Embase, and Cochrane Central Register of Controlled Trials).</p><p><strong>Results: </strong>Of the 7870 identified articles, 51 eligible studies were included . Articles outlined side effects from chemotherapy (n = 31), radiotherapy (n = 6), chemoradiation (n = 9), chemotherapy and targeted therapy (n = 2), and chemotherapy, radiotherapy, and targeted therapy (n = 3). The most prevalent side effects reported were nausea and vomiting (chemotherapy), radiation dermatitis (radiotherapy), neutropenia, and anaemia (chemoradiation). Included studies reported an increased risk of side effects related to combined therapy (i.e., chemoradiation), type of chemotherapy, higher cumulative chemotherapy doses, more frequent treatment cycles, and the presence of comorbidities. Six studies indicated treatment discontinuation arising due to treatment-related side effects.</p><p><strong>Conclusion: </strong>The review highlights the need for cancer care providers to anticipate treatment-related side effects and mitigate them ahead of time, providing necessary prophylactic measures and treatment support.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 4","pages":"356"},"PeriodicalIF":2.8,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring what constitutes \"a good day\" for individuals living with advanced cancer: a qualitative interview study.","authors":"Svea Cheng, David Lazris, Christianna Bartel, Krina C Durica, Leeann Chen, Jennifer Fedor, Carissa A Low","doi":"10.1007/s00520-025-09397-7","DOIUrl":"https://doi.org/10.1007/s00520-025-09397-7","url":null,"abstract":"<p><strong>Purpose: </strong>More people are living longer with stage IV cancer due to advances in cancer treatments. However, individuals living with advanced cancer must navigate unique day-to-day challenges and experiences that may be incompletely understood by their health care team. This study aims to better understand the activities, decisions, and experiences that characterize a \"good day\" versus a \"bad day\" for individuals living with advanced cancer.</p><p><strong>Methods: </strong>Twenty participants with stage IV cancer completed semi-structured interviews which involved rating the quality of their day as well as characterizing their experiences and activities during the day. Participants were also asked to describe a theoretical \"very good day\" versus a \"very bad day\" for them personally, as well as advice they would give to another patient with advanced cancer about how to make a day better. Thematic analysis was used to analyze interview transcripts and identify common themes across participants.</p><p><strong>Results: </strong>Interviews revealed that \"good days\" were associated with feeling like oneself before cancer, bringing oneself to engage in activities that bring wellness and joy, feeling connected to others, feeling accomplished, and practicing positive thought patterns. On the other hand, loss of control, uncertainty/unpredictability, disruptive physical symptoms, negative experiences with health care, and inability to reach one's goals were common on \"bad days.\"</p><p><strong>Conclusions: </strong>This qualitative study highlighted common themes in what defines good and bad days living with stage IV cancer. Understanding individual values and priorities may help care teams support people with advanced cancer to optimize their quality of life and functioning and navigate treatment decisions.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 4","pages":"352"},"PeriodicalIF":2.8,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Time-restricted eating to address persistent cancer-related fatigue among cancer survivors: a randomized controlled trial.","authors":"Amber S Kleckner, Carin L Clingan, Shari M Youngblood, Ian R Kleckner, Lauren Quick, Rebecca D Elrod, Shijun Zhu, Emily N C Manoogian, Satchidananda Panda, Ashraf Z Badros, Ashkan Emadi","doi":"10.1007/s00520-025-09394-w","DOIUrl":"https://doi.org/10.1007/s00520-025-09394-w","url":null,"abstract":"<p><strong>Purpose: </strong>Time-restricted eating (TRE) helps regulate rest-activity rhythms, blood glucose, and other diurnally regulated energetics processes, which may have implications for persistent fatigue. In a randomized controlled trial, we tested the effects of TRE vs. control on fatigue in cancer survivorship.</p><p><strong>Methods: </strong>Adult cancer survivors were recruited who were 2 months to 2 years post-treatment and reported moderate to severe fatigue. Participants were randomized 1:1, TRE:control, and all received individualized nutrition counseling. The TRE group self-selected a 10-h eating window for 12 weeks. At baseline, week 6, and week 12, participants were asked to log eating instances, complete the Functional Assessment of Chronic Illness Therapy-Fatigue questionnaire (FACIT-F, higher score = less fatigue), and wear an actigraph and continuous glucose monitor.</p><p><strong>Results: </strong>Thirty participants completed baseline assessments and were randomized (77% female, 53% Black/African American, 43% White, 7% Hispanic; 54.1 ± 14.7 years old; 87% with blood cancer); 25 completed 12-week assessments. TRE led to a meaningful reduction in fatigue at week 12 controlling for baseline levels (change in FACIT-F fatigue subscale = 0.0 ± 5.4 for control, 4.1 ± 5.7 for TRE, p = 0.11, effect size (ES) = 0.70; clinically meaningful threshold = 3.0 points). Glucose parameters (e.g., average interstitial glucose, average fasting glucose) tended to be lower, and rest-activity rhythms tended to indicate more regularity for those in the TRE vs. control group at weeks 6 and 12, though differences were not statistically significant (p > 0.19).</p><p><strong>Conclusions: </strong>A 12-week, nutritionist-led TRE program led to less fatigue than control. Continued study of TRE patterns are warranted to optimize this eating pattern and address persistent cancer-related fatigue.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT05256888.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 4","pages":"353"},"PeriodicalIF":2.8,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Influence of photobiomodulation on sensory symptoms, balance, and gait speed in chemotherapy-induced peripheral neuropathy.","authors":"Laura Santamarina, Mariane Oliveira de Souza, Larissa Ansani Sassaron, Talita Dos Santos Ezequiel, Regiane Luz Carvalho, Vanessa Fonseca Vilas Boas, Laura Ferreira de Rezende","doi":"10.1007/s00520-025-09405-w","DOIUrl":"https://doi.org/10.1007/s00520-025-09405-w","url":null,"abstract":"<p><strong>Introduction: </strong>Photobiomodulation (PBM) is a non-invasive therapy that uses low-level light in the visible and near-infrared spectrum to stimulate cellular processes, promoting tissue repair and reducing inflammation without causing thermal damage. PBM has shown potential in alleviating neuropathic pain and improving nerve function by enhancing mitochondrial activity, reducing oxidative stress, and modulating inflammatory pathways. Emerging evidence suggests that PBM may be a promising adjunctive treatment for managing chemotherapy-induced peripheral neuropathy (CIPN) and improving patients' quality of life.</p><p><strong>Objective: </strong>To evaluate the influence of photobiomodulation (PBM) on sensory complaints, balance, and gait speed in patients with chemotherapy-induced peripheral neuropathy (CIPN).</p><p><strong>Methods: </strong>Prospective clinical study in 47 patients with CIPN in the lower limbs (CAAE: 70504423.9.0000.5382). Patients received PBM (630/850 nm), in the nerve pathway, 2 × /week for 2 weeks. The Neuropathic Pain Questionnaire (DN-4), the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (FANPIQ) and its interference items, and the Lower Extremity Functional Scale (LEFS) were used. Balance was assessed by measuring the amplitude, speed, and area of displacement with a force platform on rigid and deformable surfaces. Gait speed (GS) was assessed by the 10-m walk test. Measurements were collected at the beginning and end of treatment and analyzed with descriptive statistics and independent t-test.</p><p><strong>Results: </strong>Sensory symptoms improved, as evidenced by the results of the DN-4 (p < 0.0001) and the FANPIQ (p = 0.0031), but not in the LEFS (p = 0.2379). There was also a significant improvement in the amplitude of the anteroposterior displacement (APD) and in the amplitude of the mediolateral displacement (MLD) (p = 0.0001 and p < 0.0001), in the velocity of the APD and MLD (p = 0.0431 and p = 0.0016), and in the displacement area (p = 0.0001). On the deformable surface, significant reductions were also observed in the APD and MLD (p = 0.0314 and p = 0.0008), as well as in the velocity of the MLD (p = 0.0091) and displacement area (p = 0.0029). GS showed improvement (p = 0.0315).</p><p><strong>Conclusion: </strong>PBM proved to be a promising low-cost resource for the management of sensory symptoms of CIPN, with positive clinical repercussions on balance and gait speed.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 4","pages":"355"},"PeriodicalIF":2.8,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction to: Testing items to screen for religious or spiritual distress in adult outpatient cancer care.","authors":"Dirk Labuschagne, Patricia K Palmer, Teresa Deshields, James Gerhart, George Fitchett","doi":"10.1007/s00520-025-09424-7","DOIUrl":"https://doi.org/10.1007/s00520-025-09424-7","url":null,"abstract":"","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 4","pages":"354"},"PeriodicalIF":2.8,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Utilization outcomes of a cancer rehabilitation (CRNav) program: getting to the quadruple aim in cancer care.","authors":"Shana E Harrington, Nicole L Stout, Ashley W Perry, Mindi R Manes, Meryl J Alappattu, Kailyn Horn","doi":"10.1007/s00520-025-09388-8","DOIUrl":"10.1007/s00520-025-09388-8","url":null,"abstract":"<p><strong>Background: </strong>A cancer rehabilitation navigation (CRNav) program is an evidence-based care delivery model that uses a rehabilitation professional in the navigation role to support oncology care delivery, provide functional screening for early identification of impairment, and coordinate care delivery services to optimize early rehabilitation. There is limited research showing how a CRNav impacts healthcare utilization. The objective of this study was to assess utilization data for a CRNav Program and demonstrate how the program influences the effectiveness of cancer care delivery and patient and provider satisfaction.</p><p><strong>Methods: </strong>Data was collected from the electronic health record of the Brooks Rehabilitation/Halifax systems at a community cancer center to assess program and service utilization over 3.2 years using a retrospective design.</p><p><strong>Results: </strong>Over 3.2 years, the CRNav program received 1585 referrals and screened 1447 (91.3%) patients. Of the 1447 screenings performed, 73.6% were recommended to receive outpatient rehabilitation (n = 1065). Among patients screened, breast cancer was the most common cancer diagnosis (47%) followed by head and neck cancers (14%). There were 638 total rehabilitation visits identified for patients who were seen for services within the health system, with physical therapy encounters accounting for the greatest number (n = 462). The most common reasons for receiving physical therapy services included lymphedema (27%), pain (25%), and limited range of motion (12%). Patients reported high satisfaction (≥ 95.4%) in the areas of how well rehabilitation met expectations and overall satisfaction with the rehabilitation experience.</p><p><strong>Conclusions: </strong>Using a CRNav in a community cancer center resulted in efficient care of patients with cancer, improved patient satisfaction and patient outcomes, and an enhanced clinician experience. This program provides a value-based approach to care supporting the quadruple aim and improving the identification and management of cancer-related functional morbidity.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 4","pages":"357"},"PeriodicalIF":2.8,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}